424 related articles for article (PubMed ID: 26797355)
21. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Kodama M; Kamata N
Abdom Imaging; 2009; 34(3):381-4. PubMed ID: 18437450
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features.
Zhang X; Liu X; Joseph L; Zhao L; Hart J; Xiao SY
Hum Pathol; 2014 Mar; 45(3):621-7. PubMed ID: 24457081
[TBL] [Abstract][Full Text] [Related]
23. Use of diffusion-weighted MRI to differentiate chronic pancreatitis from pancreatic cancer.
Sandrasegaran K; Nutakki K; Tahir B; Dhanabal A; Tann M; Cote GA
AJR Am J Roentgenol; 2013 Nov; 201(5):1002-8. PubMed ID: 24147470
[TBL] [Abstract][Full Text] [Related]
24. MRCP and MRI findings in 9 patients with autoimmune pancreatitis.
Kamisawa T; Chen PY; Tu Y; Nakajima H; Egawa N; Tsuruta K; Okamoto A; Kamata N
World J Gastroenterol; 2006 May; 12(18):2919-22. PubMed ID: 16718819
[TBL] [Abstract][Full Text] [Related]
25. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
26. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
[TBL] [Abstract][Full Text] [Related]
27. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
Huang XM; Shi ZS; Ma CL
World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
[TBL] [Abstract][Full Text] [Related]
28. Differentiation of focal-type autoimmune pancreatitis from pancreatic carcinoma: assessment by multiphase contrast-enhanced CT.
Furuhashi N; Suzuki K; Sakurai Y; Ikeda M; Kawai Y; Naganawa S
Eur Radiol; 2015 May; 25(5):1366-74. PubMed ID: 25433412
[TBL] [Abstract][Full Text] [Related]
29. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
30. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
31. Clinical differences between mass-forming autoimmune pancreatitis and pancreatic cancer.
Naitoh I; Nakazawa T; Hayashi K; Okumura F; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Ohara H; Joh T
Scand J Gastroenterol; 2012 May; 47(5):607-13. PubMed ID: 22416894
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic duct abnormalities in focal autoimmune pancreatitis: MR/MRCP imaging findings.
Negrelli R; Manfredi R; Pedrinolla B; Boninsegna E; Ventriglia A; Mehrabi S; Frulloni L; Pozzi Mucelli R
Eur Radiol; 2015 Feb; 25(2):359-67. PubMed ID: 25106489
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas.
Fattahi R; Balci NC; Perman WH; Hsueh EC; Alkaade S; Havlioglu N; Burton FR
J Magn Reson Imaging; 2009 Feb; 29(2):350-6. PubMed ID: 19161187
[TBL] [Abstract][Full Text] [Related]
34. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies.
Kim B; Lee SS; Sung YS; Cheong H; Byun JH; Kim HJ; Kim JH
J Magn Reson Imaging; 2017 Jan; 45(1):260-269. PubMed ID: 27273754
[TBL] [Abstract][Full Text] [Related]
35. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of CT and MRI for differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma.
Ha J; Choi SH; Byun JH; Kim KW; Kim SY; Kim JH; Kim HJ
Eur Radiol; 2021 May; 31(5):3427-3438. PubMed ID: 33146798
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
[TBL] [Abstract][Full Text] [Related]
38. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
[TBL] [Abstract][Full Text] [Related]
39. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma.
Liu K; Peng W; Zhou Z
Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737
[TBL] [Abstract][Full Text] [Related]
40. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]